Deal or Case news
NautaDutilh assisted LUMICKS Technologies B.V. with its $93 million Series D financing round. The financing round was led by new investors Farallon Capital Management and Lauxera Capital Partners.

The round included investments by Softbank Vision, funds and accounts advised by T. Rowe Price Associates, Parian Global Management, Pura Vida Investments and Irving Investors and was backed by existing investor Gilde Healthcare and select members of LUMICKS' management team.

LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. These instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells.

For press release and media attention, please see:

LUMICKS Technologies -

FD  -…

NautaDutilh's team consisted of Paul van der Bijl, Ruud Smits, Sanne Meester, Leanne Meurs,  Joppe Schoute and Daan Hagelstein.

Related articles

Cookie notification

This functionality uses third-party cookies. Change your cookie preferences to view this content or view more information.
These cookies ensure that the website works properly. These cookies cannot be disabled.
These cookies can be placed by third parties, such as YouTube or Vimeo.
By deactivating categories, it is possible that related functionalities within the website may no longer work properly. It is always possible to change your preferences at a later time. View more information.